Home > Blog > The influence of mdrs article 117 in the marketing of combination products

The Influence of MDR’s Article 117 in the Marketing of Combination Products

Regulatory Consulting

The European Union Medical Device Regulation’s (MDR) Article 117 brings improved patient safety measures with new implications for manufacturers, as they must fulfill a significant set of additional requirements.

Listen to the full episode on Veristat’s Advancing Revolutionary Therapies Podcast to learn more about the Article and its influence on the marketing of combination products.

Learning Points

  • What are Drug Device Combination (DDC) products
  • What is Article 117 of the MDR
  • The impact of Article 117 on Manufacturers

LISTEN TO PODCAST

 

Meet Veristat. Learn More.

1 min read

Meet Veristat at BIO-Europe Spring: March 23-25, 2026 - Lisbon, Portugal

Mar 23, 2026  Veristat Events

🔬 Connecting with the Global Biopharma Community

Veristat is pleased to attend BIO-Europe Spring, where biotech...

1 min read

Meet Veristat at PHUSE US Connect: Advancing Data-Driven Clinical Development

Mar 18, 2026  Veristat Events

🔬 Connecting with the Global Clinical Data and Biostatistics Community

Veristat is pleased to attend PHUSE US Connect...